{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:02:30Z","timestamp":1790514150109,"version":"4.1.0"},"reference-count":23,"publisher":"JLE","issue":"4","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.nephro.2016.07.455","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T03:30:18Z","timestamp":1486611018000},"page":"245-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Central retinal vein occlusion in a patient on hemodialysis secondary to antiphospholipid syndrome: Case report"],"prefix":"10.1684","volume":"13","author":[{"given":"Marouane","family":"Jabrane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Med Reda","family":"Ez-Zahraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibtissam","family":"Hajji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa","family":"Fadili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdeljalil","family":"Moutaouakil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inass","family":"Laouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2016.07.455_bib0120","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nephro.2016.07.455_bib0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.nephro.2016.07.455_bib0130","first-page":"342","article-title":"The antiphospholipid syndrome: ten years on","volume":"341","author":"Hughes","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2016.07.455_bib0135","first-page":"1742","article-title":"A \u201cprimary\u201d antiphospholipid syndrome","volume":"15","author":"Asherson","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.nephro.2016.07.455_bib0140","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000\u00a0patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nephro.2016.07.455_bib0145","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ndt\/6.8.543","article-title":"Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease","volume":"6","author":"Garcia-Martin","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2016.07.455_bib0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000184984","article-title":"Lupus-like in vitro anticoagulant activity in end-stage renal disease","volume":"49","author":"Quereda","year":"1988","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2016.07.455_bib0155","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/bmj.300.6741.1696","article-title":"Raised concentrations of antibodies to cardiolipin in patients receiving dialysis","volume":"300","author":"Gronhagen-Riska","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.nephro.2016.07.455_bib0160","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ki.1995.352","article-title":"Antiphospholipid in hemodialysis patients: relationship between lupus anticoagulant and thrombosis","volume":"58","author":"Brunet","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2016.07.455_bib0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0003-4975(99)00458-0","article-title":"Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients","volume":"68","author":"Fastenau","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.nephro.2016.07.455_bib0170","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.semarthrit.2006.01.001","article-title":"Antiphospholipid syndrome and the kidneys","volume":"35","author":"Uhtman","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.nephro.2016.07.455_bib0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01698134","article-title":"Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus","volume":"65","author":"Sitter","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1016\/j.nephro.2016.07.455_bib0180","first-page":"89","article-title":"Antiphospholipid (aPL) antibodies in end-stage renal disease","volume":"12","author":"Fabrizi","year":"1999","journal-title":"J Nephrol"},{"key":"10.1016\/j.nephro.2016.07.455_bib0185","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ndt\/7.12.1194","article-title":"Are antiphospholipid antibodies clinically relevant in dialysis patients?","volume":"7","author":"Chew","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2016.07.455_bib0190","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000045833","article-title":"Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: cause or effect","volume":"86","author":"Haviv","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2016.07.455_bib0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0272-6386(95)90656-8","article-title":"Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis","volume":"26","author":"Prakash","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2016.07.455_bib0200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1072-7515(99)00086-1","article-title":"Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access","volume":"189","author":"Lesar","year":"1999","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.nephro.2016.07.455_bib0205","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ki.2011.477","article-title":"IgA antibodies against \u03b22 glycoprotein\u00a0I in hemodialysis patients are an independent risk factor for mortality","volume":"81","author":"Serrano","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2016.07.455_bib0210","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J Rheumatol"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.nephro.2016.07.455_bib0215","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1177\/096120339800700214","article-title":"The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment","volume":"7","author":"Asherson","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.nephro.2016.07.455_bib0220","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","article-title":"Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80\u00a0patients","volume":"80","author":"Asherson","year":"2001","journal-title":"Medecine (Baltimore)"},{"key":"10.1016\/j.nephro.2016.07.455_bib0225","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.autrev.2011.04.031","article-title":"Management of refractory cases of catastrophic antiphospholipid syndrome","volume":"10","author":"Espinosa","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.nephro.2016.07.455_bib0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1056\/NEJMoa1312890","article-title":"Inhibition of the mTORC pathway in the antiphospholipid syndrome","volume":"371","author":"Canaud","year":"2014","journal-title":"N Engl J Med"}],"container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725516306393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725516306393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2016.07.455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:38:57Z","timestamp":1741192737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725516306393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1769725516306393"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2016.07.455","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central retinal vein occlusion in a patient on hemodialysis secondary to antiphospholipid syndrome: Case report","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2016.07.455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Association Soci\u00e9t\u00e9 de n\u00e9phrologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}